Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | +8.75% |
|
+8.02% | -67.58% |
01:00pm | CellProthera and BioCardia, Inc. Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction | CI |
Jun. 10 | Top Premarket Decliners | MT |
- Stock Market
- Equities
- BCDA Stock
- News BioCardia, Inc.
- Trading Ideas